Skip to main content
. 2021 Nov 5;9:742355. doi: 10.3389/fpubh.2021.742355

Table 1.

Baseline characteristics for patients with HCC.

Overall UEBMI URRBMI P
(N = 2,068) (N = 1,498) (N = 570)
Demographic characteristics
   Age [Mean (SD)] 60.7 (12.6) 60.6 (12.9) 60.9 (11.6) 0.667
   Female [N (%)] 634 (30.7%) 476 (31.8%) 158 (27.7%) 0.074
Comorbidities and complications [N (%)]
   CCI score [Mean (SD)] 4.44 (2.16) 4.69 (2.23) 3.78 (1.81) <0.001
Comorbidities related to the liver
Hepatitis 916 (44.3%) 660 (44.1%) 256 (44.9%) 0.727
   HBV 741 (35.8%) 525 (35.0%) 216 (37.9%) 0.227
   HCV 82 (4.0%) 69 (4.6%) 13 (2.3%) 0.015
Cirrhosis of the liver 939 (45.4%) 663 (44.3%) 276 (48.4%) 0.089
Compensated cirrhosis 490 (23.7%) 365 (24.4%) 125 (21.9%) 0.244
Decompensated cirrhosis 449 (21.7%) 298 (19.9%) 151 (26.5%) 0.001
Hepatic failure 266 (12.9%) 176 (11.7%) 90 (15.8%) 0.014
Fatty liver disease 92 (4.4%) 79 (5.3%) 13 (2.3%) 0.003
Alcoholic liver disease 52 (2.5%) 42 (2.8%) 10 (1.8%) 0.173
Ascites 366 (17.7%) 232 (15.5%) 134 (23.5%) <0.001
Hepatic encephalopathy 202 (9.8%) 151 (10.1%) 51 (8.9%) 0.438
Jaundice 137 (6.6%) 104 (6.9%) 33 (5.8%) 0.346
Portal hypertension 82 (4.0%) 57 (3.8%) 25 (4.4%) 0.545
Esophageal variceal bleeding 54 (2.6%) 38 (2.5%) 16 (2.8%) 0.731
Primary peritonitis 52 (2.5%) 37 (2.5%) 15 (2.6%) 0.834
Hepatorenal syndrome 35 (1.7%) 31 (2.1%) 4 (0.7%) 0.031
All-cause resource utilization and costs
   Total cost [Mean(SD), CNY] 7,505 (16,870) 8,940 (17,501) 3,733 (14, 435) <0.001
   Any hospitalizations [N (%)] 428 (20.7%) 314 (21.0%) 114 (20.0%) 0.630
   ALOS per hospitalization [Mean(SD)] 12.9 (10.5) 14.0 (11.4) 9.9 (6.6) <0.001
   Any outpatient visits [N (%)] 1,578 (76.3%) 1,424 (95.1%) 154 (27.0%) <0.001

CCI score, Charlson Comorbidity Index score; HBV, hepatitis B virus; HCV, hepatitis C virus; CNY, Chinese yuan (year-2017 1 USD = 6.77 CNY); ALOS, Average length of stay.

Patients with liver cirrhosis who had the following symptoms were defined as decompensated liver cirrhosis: ascites; esophageal variceal bleeding; hepatorenal syndrome; portal hypertension; hepatic encephalopathy and jaundice; hepatic encephalopathy and primary peritonitis; jaundice and primary peritonitis.

Including alcoholic liver cirrhosis, alcoholic hepatitis, alcoholic fatty liver disease and alcoholic liver failure; hepatitis, liver cirrhosis, fatty liver disease and liver failure in this table only included non-alcoholic disease. Bold values means P < 0.05.